Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$52.63 -0.74 (-1.39%)
Closing price 04:00 PM Eastern
Extended Trading
$52.62 -0.02 (-0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LIVN vs. PEN, STVN, IRTC, BLCO, GKOS, TMDX, SLNO, NVST, WRBY, and INSP

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

LivaNova vs. Its Competitors

LivaNova (NASDAQ:LIVN) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Penumbra has a net margin of 11.54% compared to LivaNova's net margin of -16.13%. LivaNova's return on equity of 14.57% beat Penumbra's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova-16.13% 14.57% 6.91%
Penumbra 11.54%11.55%8.76%

LivaNova has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500.

LivaNova has higher earnings, but lower revenue than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.25B2.29$63.23M-$3.89-13.53
Penumbra$1.28B7.78$14.01M$3.7667.91

In the previous week, Penumbra had 10 more articles in the media than LivaNova. MarketBeat recorded 19 mentions for Penumbra and 9 mentions for LivaNova. Penumbra's average media sentiment score of 0.95 beat LivaNova's score of 0.17 indicating that Penumbra is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
0 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Penumbra
11 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

97.6% of LivaNova shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 4.2% of Penumbra shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

LivaNova presently has a consensus price target of $59.71, suggesting a potential upside of 13.46%. Penumbra has a consensus price target of $302.93, suggesting a potential upside of 18.63%. Given Penumbra's stronger consensus rating and higher probable upside, analysts plainly believe Penumbra is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
Penumbra
0 Sell rating(s)
4 Hold rating(s)
13 Buy rating(s)
1 Strong Buy rating(s)
2.83

Summary

Penumbra beats LivaNova on 13 of the 17 factors compared between the two stocks.

Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.87B$7.01B$6.10B$10.62B
Dividend YieldN/A1.10%5.64%4.70%
P/E Ratio-13.5327.4685.6627.12
Price / Sales2.29194.37527.81205.91
Price / Cash12.5922.4126.3031.12
Price / Book2.165.2912.906.66
Net Income$63.23M$178.04M$3.30B$275.95M
7 Day Performance0.57%3.47%4.79%3.32%
1 Month Performance-9.21%10.09%8.10%10.77%
1 Year Performance-2.23%29.22%75.74%33.55%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
2.4552 of 5 stars
$52.63
-1.4%
$59.71
+13.5%
-0.9%$2.87B$1.25B-13.532,900Positive News
PEN
Penumbra
4.6457 of 5 stars
$252.02
-0.5%
$302.93
+20.2%
+31.5%$9.88B$1.19B67.034,500Insider Trade
STVN
Stevanato Group
2.0298 of 5 stars
€25.46
-0.8%
N/A+37.3%€7.77B€1.15B47.155,521
IRTC
iRhythm Technologies
1.1553 of 5 stars
$169.50
-0.8%
$167.50
-1.2%
+180.0%$5.49B$591.84M-57.852,000
BLCO
Bausch + Lomb
1.8789 of 5 stars
$14.98
+3.3%
$15.56
+3.9%
-20.0%$5.13B$4.79B-19.2013,500
GKOS
Glaukos
4.5123 of 5 stars
$81.24
+1.7%
$123.58
+52.1%
-33.2%$4.58B$383.48M-49.24780
TMDX
TransMedics Group
3.3484 of 5 stars
$112.64
-1.1%
$125.40
+11.3%
-16.8%$3.88B$441.54M58.36210Positive News
SLNO
Soleno Therapeutics
4.1752 of 5 stars
$68.16
+4.9%
$115.09
+68.9%
+19.3%$3.45BN/A-16.4630
NVST
Envista
3.6804 of 5 stars
$20.22
-0.7%
$20.92
+3.5%
+10.7%$3.38B$2.51B63.1712,300Positive News
WRBY
Warby Parker
1.8217 of 5 stars
$27.69
+0.3%
$24.06
-13.1%
+62.6%$2.90B$771.32M-395.513,780Positive News
Analyst Forecast
INSP
Inspire Medical Systems
4.8479 of 5 stars
$75.46
-2.3%
$154.43
+104.6%
-64.4%$2.28B$802.80M43.621,246

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners